Summary - A new market study, titled “Cancer Immunotherapy Market Research Report- Forecast till 2023” has been featured on The global  Leather Footwear market is valued at US$ xx million in 2023 is expected to reach US$ xx million by the end of 2023, growing at a CAGR of xx% during 2023.

Report Description

This report analyzes the global cancer immunotherapy market by type of therapy (monoclonal antibodies, adoptive cell transfer and others), by application (lung cancer, childhood cancer and other), by end user (hospitals, clinics & others); it also studies the top manufacturers in the market.


The global cancer immunotherapy market was valued at USD 36.8 billion in 2016 and is projected to reach USD 101.6 billion by 2023, at a CAGR of 14.8% during the forecast period.

The major players in global cancer immunotherapy market include:

  • F. Hoffmann-La Roche AG
  • Merck & Co., Inc.
  • Novartis International AG
  • GlaxoSmithKline Plc.
  • Amgen Inc.
  • Bristol-Myers Squibb
  • ELI Lilly and Company
  • Celgene Corporation
  • Seattle Genetics, Inc.
  • Spectrum Pharmaceuticals, Inc.

The market revenue and share have been analyzed with respect to the following regions and countries:


North America



    South America


Western Europe






Rest of Western Europe

    Eastern Europe

Asia Pacific





Republic of Korea

Rest of Asia Pacific

Middle East & Africa

    United Arab Emirates

    Saudi Arabia




    Rest of the Middle East & Africa   

On the basis of type of therapy, the global cancer immunotherapy market has been categorized into the following segments:


  • Monoclonal Antibodies
  • Adoptive Cell Transfer
  • Others

On the basis of application, the global cancer immunotherapy market has been categorized into the following segments:

  • Lung Cancer
  • Childhood Cancer
  • Other

On the basis of end user, the global cancer immunotherapy market has been categorized into the following segments:

  • Hospitals
  • Clinics
  • Others

Research Methodology

Market Research Future analysis is conducted by industry experts who offer insight into industry structure, market segmentation, technology assessment, competitive landscape (CL), and market penetration, as well as on emerging trends. Besides primary interviews (~80%) and secondary research (~20%), their analysis is based on years of professional expertise in their respective industries. Our analysts also predict where the market will be headed in the next five to 10 years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments and categories in different regions are estimated based on primary and secondary research.

Both the top-down and bottom-up approaches were used to estimate and validate the size of the market and to estimate the size of various other dependent sub-markets. The key players in the market were identified through secondary research, and their market contributions in the respective regions were determined through primary and secondary research. This entire process included the study of the annual and financial reports of the top market players and extensive interviews for key insights with industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares, splits, and breakdowns were determined using secondary sources and verified through primary sources. All the possible parameters that affect the market covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to arrive at the final quantitative and qualitative data. This data has been consolidated, and detailed inputs and analysis by Market Research Future added before being presented in this report



About Us: 

Wise Guy Reports is part of the Wise Guy Research Consultants Pvt. Ltd. and offers premium progressive statistical surveying, market research reports, analysis & forecast data for industries and governments around the globe.         


Contact Us:               

NORAH TRENT                                                      

[email protected]       

Ph: +162-826-80070 (US)                          

Ph: +44 203 500 2763 (UK)